GT
33
3
PNW
52
-3
WMT
70
3
BMY
41
-2
C
51
-7
WEC
41
-5
JPM
50
-5
APH
52
-7
AMP
44
-8
FFIV
62
-4
QCOM
50
-2
PNR
47
-6
CF
56
2
AMT
24
-4
DTE
56
-7
AEP
59
5
VRSN
58
-2
OMC
33
-2
AVB
47
-2
GLW
46
-3
GT
33
3
PNW
52
-3
WMT
70
3
BMY
41
-2
C
51
-7
WEC
41
-5
JPM
50
-5
APH
52
-7
AMP
44
-8
FFIV
62
-4
QCOM
50
-2
PNR
47
-6
CF
56
2
AMT
24
-4
DTE
56
-7
AEP
59
5
VRSN
58
-2
OMC
33
-2
AVB
47
-2
GLW
46
-3
Financhill
Back

Traws Pharma 10K Form

Buy
56

TRAW
Traws Pharma

Last Price:
$8.08
Seasonality Move:
4.31%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive TRAW News And Ratings

See the #1 stock for the next 7 days that we like better than TRAW

TRAW Financial Statistics

Sales & Book Value

Annual Sales: $226K
Cash Flow: $-11.5M
Price / Cash Flow: 0
Annual Sales: $-0.67
Price / Book: 2.78

Profitability

EPS (TTM): -141.47000
Net Income (TTM): $-140.8M
Gross Margin: --
Return on Equity: -124.39%
Return on Assets: -736.98%

Traws Pharma Earnings Forecast

Key Traws Pharma Financial Ratios

  • The Research & Development expenses have been 5,057.52% of Revenue.
  • The Net Earning history of TRAW is -8,384.07% of Total Revenues.
  • Per Share Earnings over the last 13 years have been positive in 10 years.

Traws Pharma Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: TRAW
Website: onconova.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 1.07
Quick Ratio: 0.9

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

TRAW Technical Analysis vs Fundamental Analysis

Buy
56
Traws Pharma (TRAW) is a Buy

Is Traws Pharma a Buy or a Sell?

  • Traws Pharma stock is rated a Buy
    The current Traws Pharma [TRAW] share price is $8.06. The Score for TRAW is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.